ADORN 发表于 2025-3-23 13:18:15

Submitted on: 02 July 2007.
Revised on: 25 October 2007.
Accepted on: 09 December 2007.

___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

headway 发表于 2025-3-23 17:42:46

http://reply.papertrans.cn/1/69/6859/6859-12.png

slipped-disk 发表于 2025-3-23 19:04:05

http://reply.papertrans.cn/1/69/6859/6859-13.png

Defense 发表于 2025-3-23 23:34:27

Submitted on: 28 December 2014.
Revised on: 16 February 2015.
Accepted on: 08 April 2015.

___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

Cholecystokinin 发表于 2025-3-24 03:09:40

Submitted on: 09 August 2017.
Revised on: 04 December 2017.
Accepted on: 16 January 2018.

___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

osteopath 发表于 2025-3-24 09:31:55

http://reply.papertrans.cn/1/69/6859/6859-16.png

果核 发表于 2025-3-24 11:04:16

Submitted on: 13 October 2022.
Revised on: 28 January 2023.
Accepted on: 14 February 2023.

___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

strain 发表于 2025-3-24 18:30:03

http://reply.papertrans.cn/1/69/6859/6859-18.png

斜 发表于 2025-3-24 21:55:43

http://reply.papertrans.cn/1/69/6859/6859-19.png

Madrigal 发表于 2025-3-25 02:31:20

Submitted on: 28 August 2007.
Revised on: 25 October 2007.
Accepted on: 22 December 2007.

___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD
页: 1 [2] 3 4
查看完整版本: SCIE期刊CURRENT CANCER DRUG TARGETS 2024/2025影响因子:2.326 (CURR CANCER DRUG TAR) (1568-0096). (ONCOLOGY)(肿瘤学)Science Citati